Abstract
We report a case series of two patients with chronic kidney disease (CKD) who developed erythropoietin-induced pure red cell aplasia following a change in erythropoietin preparation. Both patients responded well to immunosuppressive treatments, but unfortunately developed severe infections as a result of being immunosuppressed.
Keywords:
Erythropoietin; Pure red cell aplasia.
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
MeSH terms
-
Aged
-
Erythropoietin* / adverse effects
-
Erythropoietin* / therapeutic use
-
Female
-
Hematinics / adverse effects
-
Hematinics / therapeutic use
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Kidney Failure, Chronic
-
Male
-
Middle Aged
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
-
Red-Cell Aplasia, Pure* / chemically induced
Substances
-
Erythropoietin
-
Immunosuppressive Agents
-
Hematinics
-
Recombinant Proteins